Jason A. Leverone, Chief Financial Officer at OnKure Therapeutics, Inc. (OKUR), sold 302 shares at $2.97 ($898) on 2026-09-21, disclosed to the SEC on 2026-09-23.
Open-market sale of $898 OKUR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| OKUR | SELL | 2025-12-23 | $897 | — | Filing → |
| OKUR | SELL | 2025-09-24 | $794 | — | Filing → |
| OKUR | SELL | 2025-06-25 | $721 | — | Filing → |